Oramed Pharmaceuticals Inc. ORMP
3.92 USD +0.03 (+0.77%)
Nov 6, 2026, 11:12 AM EST
3.89 Day range 4.00
2.09 52-week range 5.47
- YTD
- +37.54%
- 1 year
- +78.18%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Aug 31, 2021 |
|---|---|---|---|---|---|
| 2.00M | 0 | 1.34M | 2.70M | 2.70M | |
| 13.00K | 0 | 1.34M | 2.70M | 2.70M | |
| -15.09M | -12.78M | -15.77M | -40.60M | -24.22M | |
| 64.05M | -19.06M | 5.53M | -36.56M | -22.24M | |
| 1.50 | -0.48 | 0.14 | -0.94 | -0.78 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Aug 31, 2021 |
|---|---|---|---|---|---|
| 45.95M | 54.42M | 9.05M | 40.46M | 77.25M | |
| 230.86M | 155.28M | 220.55M | 161.64M | 128.00M | |
| 31.12M | 9.93M | 57.66M | 10.49M | 11.48M | |
| 825.00K | 372.00K | 51.62M | 894.00K | 533.00K | |
| 199.74M | 146.26M | 163.82M | 151.81M | 115.77M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Aug 31, 2021 |
|---|---|---|---|---|---|
| -9.14M | -8.41M | -10.29M | -27.92M | -21.18M | |
| 5.44M | 105.82M | -73.04M | 30.21M | -23.76M | |
| -4.74M | -52.04M | 51.98M | 10.78M | 102.89M | |
| -1.93M | -18.00K | -254.00K | -472.00K | -375.00K | |
| -8.47M | 45.37M | -31.41M | 13.01M | 57.95M |